UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 176 filers reported holding UNIQURE NV in Q2 2020. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,947,000 | -69.2% | 53,900 | -68.6% | 0.90% | -70.0% |
| Q3 2020 | $6,313,000 | -2.1% | 171,429 | +19.8% | 3.00% | +8.5% |
| Q2 2020 | $6,449,000 | -44.7% | 143,129 | -41.7% | 2.77% | -49.2% |
| Q1 2020 | $11,652,000 | -31.5% | 245,564 | +3.4% | 5.45% | -27.1% |
| Q4 2019 | $17,019,000 | +31.4% | 237,500 | -27.8% | 7.47% | +4.0% |
| Q3 2019 | $12,949,000 | +38.1% | 328,978 | +174.1% | 7.18% | +51.9% |
| Q2 2019 | $9,378,000 | +1070.8% | 120,000 | +251.9% | 4.73% | +841.8% |
| Q1 2018 | $801,000 | -85.6% | 34,100 | -88.0% | 0.50% | -87.8% |
| Q4 2017 | $5,578,000 | – | 284,717 | – | 4.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |